Cyprus reports surge in antibiotic-resistant infections despite lower consumption
Cyprus has recorded a significant rise in bloodstream infections caused by antibiotic-resistant bacteria between 2019 and 2025, according to the European Centre for Disease Prevention and Control (ECDC). While overall antibiotic consumption dropped by 25% since 2019, the country still ranks sixth in the EU for usage, with consumption reaching 22.2 defined daily doses per 1,000 inhabitants in 2025, well above the EU average of 18.9.
Specific bacterial strains have shown alarming growth: carbapenem-resistant Klebsiella pneumoniae increased by 715.7%, rising from 2.61 to 21.29 cases per 100,000 inhabitants. Similarly, E. coli resistant to third-generation cephalosporins rose by 275.8%, and methicillin-resistant Staphylococcus aureus (MRSA) increased by 76.2%. Dr. Zoe Pana, Dean of the University of Nicosia Medical School, highlighted that these resistant infections are increasingly difficult to treat within hospitals, creating a critical situation that demands urgent action.
Experts stress that antibiotics should never be used without specific medical assessment. As the country marks European Antibiotic Awareness Day, health officials are campaigning for better management to preserve the efficacy of existing medications.